Lenalidomide and low-dose dexamethasone in Japanese patients with newly diagnosed multiple myeloma: A phase II study

MLA

Kenshi Suzuki, et al. “Lenalidomide and Low-Dose Dexamethasone in Japanese Patients with Newly Diagnosed Multiple Myeloma: A Phase II Study.” Cancer Science, vol. 107, Mar. 2016, pp. 653–58. EBSCOhost, https://doi.org/10.1111/cas.12916.

APA

Kenshi Suzuki, Kosei Matsue, Shuichi Midorikawa, Naoki Takezako, Takaaki Chou, Yumi Ogaki, Yoshiaki Ogawa, Atsushi Shinagawa, Vanessa Houck, Annette Ervin-Haynes, Yasuhito Terui, Morio Matsumoto, Masafumi Taniwaki, Shinsuke Iida, Itaru Matsumura, Kenichi Ishizawa, Takayuki Shimizu, Hirokazu Hirata, Takashi Ikeda, … Toshiki Uchida. (2016). Lenalidomide and low-dose dexamethasone in Japanese patients with newly diagnosed multiple myeloma: A phase II study. Cancer Science, 107, 653–658. https://doi.org/10.1111/cas.12916

Chicago

Kenshi Suzuki, Kosei Matsue, Shuichi Midorikawa, Naoki Takezako, Takaaki Chou, Yumi Ogaki, Yoshiaki Ogawa, et al. 2016. “Lenalidomide and Low-Dose Dexamethasone in Japanese Patients with Newly Diagnosed Multiple Myeloma: A Phase II Study.” Cancer Science 107 (March): 653–58. doi:10.1111/cas.12916.